article thumbnail

mRNA manufacturing and research continues to grow in Victoria

Manufacturer's Monthly

The developers of the Pfizer/BioNTech COVID-19 mRNA vaccine have chosen Victoria to establish their Asia-Pacific mRNA clinical research and development centre which will form part of BioNTech’s global network. The new facility will support researchers to translate their work into medical breakthroughs. The state government has invested $1.3

article thumbnail

New Moderna facility edges closer

Manufacturer's Monthly

Moderna is also forming partnerships with Victoria’s world-leading medical research institutes and clinical trial networks, allowing Victorians to be among the first people in the world to trial new mRNA medicines for a range of health conditions. billion investment in medical research since 2014. The Victorian Government invested $12.3